首页> 外文期刊>Neuro-ophthalmology >Mechanisms of axonal elongation during regeneration of adult retinal axons
【24h】

Mechanisms of axonal elongation during regeneration of adult retinal axons

机译:成人视网膜轴突再生过程中轴突伸长的机制

获取原文
获取原文并翻译 | 示例
           

摘要

Adult retinal ganglion cells (RGCs) exihibit only a limited and transient regenerative sprouting after injury, and they fail to extend axons within the inhospitable interior of the optic nerve. The failure to regenerate axons is attributed to inhibitory proteins associated with myelin and/or the glial scar formed immediately after injuries. Under certain experimental conditions axonal regeneration is possible, and has been examined to understand the mechanisms of regenerative growth. Such conditions include replacement of the distal segment of the cut optic nerve with a peripheral nerve segment injury to the optic lens and growth of axons within their own distal environment and in vitro culture models. Expanding on these models, the mutual mechanisms which trigger de lesio formation of growth cones and support elongation of axons will be discussed. In particular, use of proteomic methods will be first presented to document that axonal regrowth is associated with regulation of certain proteins. A proteomic-genomic correlation will be then presented to link protein-regulation to transcriptomic changes. Identified proteins which seem to play a role in axonal growth have been cloned and used for transfection experiments in order to stimulate growth of axons. The presentation will sum up with novel proteins with a high potential to promote neurite growth and promise its use to manage acute neurodegenerative diseases.
机译:成年的视网膜神经节细胞(RGC)在损伤后仅表现出有限的和短暂的再生发芽,并且它们不能在视神经不能吸收的内部延伸轴突。轴突再生失败归因于与髓磷脂和/或受伤后立即形成的神经胶质瘢痕相关的抑制蛋白。在某些实验条件下,轴突再生是可能的,并且已经被检查以了解再生生长的机制。这样的情况包括用视神经透镜的周围神经节段损伤代替视神经切断的远端节段以及轴突在其自身远端环境和体外培养模型中的生长。在这些模型的扩展上,将讨论触发生长锥的疾病形成和支持轴突伸长的相互机制。特别是,首先将介绍蛋白质组学方法的使用,以证明轴突再生与某些蛋白质的调控有关。蛋白质组与基因组的相关性随后将被提出,以将蛋白质调控与转录组学改变联系起来。为了刺激轴突的生长,已鉴定出似乎在轴突生长中起作用的蛋白质已被克隆并用于转染实验。演讲将总结具有促进神经突生长的高潜力的新型蛋白质,并有望将其用于治疗急性神经退行性疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号